A researcher at the Johns Hopkins Institute of Genetic Medicine has led the effort to compile to date the largest free resource of experimental information about human proteins. Reporting in the February issue of Nature Biotechnology, the research team describes how all researchers around the world can access this data and speed their own research.
“Advances in technology have made data generation much easier, but processing it and interpreting observations are now the major hurdles in science today,” says Akhilesh Pandey, M.D., Ph.D., associate professor of biological chemistry, pathology and oncology and member of the McKusick-Nathans Institute of Genetic Medicine at Hopkins. “We’ve created a repository that incorporates easy-to-use Web forms so that all researchers can contribute and share data,” says Pandey, who coordinated this effort with scientists and software developers at the Institute of Bioinformatics, a nonprofit institute he founded in Bangalore, India, in 2002.
Like the online encyclopedia Wikipedia, Human Proteinpedia allows any researcher to contribute and edit their data as their research progresses. “Researchers will be able to quickly review what has been discovered by others about their protein of interest, speeding their own work,” says Pandey.
Human Proteinpedia contains information on when and where specific proteins are expressed or not, including in cells and tissues from diseases such as cancers; how the proteins are modified; and which other proteins they interact with. The repository includes only experimental data and doesn’t include computer-generated predictions, which may not turn out to be real. The current version of Human Proteinpedia compiles data provided by more than 71 laboratories from all over the world and contains entries for more than 15,230 human proteins.
“With the amount of proteomic data pouring in each day, however, cataloging all of human protein data by hand is a Herculean task,” says Pandey. “So we’re hoping that the scientific community will come together to contribute data generated in individual laboratories. This will not only improve the quality of the data but also increase the pace at which data is collected in a common repository. We’re excited about the enthusiasm and involvement of the entire global proteomics community and hope that we can work with companies like Google and Microsoft that are interested in enabling such data sharing and dissemination for biological data.”
Source: Johns Hopkins Medical Institutions
Related stories:
A new cellular pathway linked to cancer is identified
In the life of a cell, the response to DNA damage determines whether the cell is fated to pause and repair itself, commit suicide, or grow uncontrollably, a route leading to cancer. In a new study, published in the July 25th issue of
Cell, scientists at NYU Langone Medical Center have identified a way that cells respond to DNA damage through a process that targets proteins for disposal. The finding points to a new pathway for the development of cancer and suggests a new way of sensitizing cancer cells to treatment.
Researchers unravel key mechanism of cellular damage in aging and disease
Researchers have taken a first snapshot of how a class of highly reactive molecules inflicts cellular damage as part of aging, heart disease, stroke, cancer, diabetes, kidney disease and Alzheimer's disease to name a few. According to a study published today in the journal
Cell, researchers have discovered a tool that can monitor related damage and determine the degree to which antioxidant drugs effectively combat disease.
NIST Trumps the Clumps: Making Biologic Drugs Safer
Scientists at the National Institute of Standards and Technology have developed a technique to measure the formation of clumps of proteins in protein-based pharmaceuticals. This first systematic study clarifies the conditions under which scientists can be assured that their instruments are faithfully measuring the formation of protein aggregates, a major concern because of its impact on quality control and safety in biologic drug manufacturing.
Plants make vaccine for treating type of cancer
Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants.
New evidence of battle between humans and ancient virus
For millennia, humans and viruses have been locked in an evolutionary back-and-forth -- one changes to outsmart the other, prompting the second to change and outsmart the first. With retroviruses, which work by inserting themselves into their host's DNA, the evidence remains in our genes.
Researchers use salmonella to administer vaccines
(PhysOrg.com) -- Researchers at the Biodesign Institute at Arizona State University have made a major step forward in their work to develop a biologically engineered organism that can effectively deliver an antigen in the body. The researchers report that they have been able to use live salmonella bacterium as the containment/delivery method for an antigen.
A Viral Cloaking Device: Biologists show how Human Cytomegalovirus hides from the immune system
(PhysOrg.com) -- Viruses achieve their definition of success when they can thrive without killing their host. Now, biologists Pamela Bjorkman and Zhiru Yang of the California Institute of Technology have uncovered how one such virus, prevalent in humans, evolved over time to hide from the immune system.
Researchers Discover Remnant of an Ancient 'RNA World'
(PhysOrg.com) -- Some bacterial cells can swim, morph into new forms and even become dangerously virulent - all without initial involvement of DNA. Yale University researchers describe Friday in the journal
Science how bacteria accomplish this amazing feat - and in doing so provide a glimpse of what the earliest forms of life on Earth may have looked like.